Working with the sponsorship of the Morris Animal Foundation and colleagues at five major veterinary medical academic centers in the US, Europe, and South America, RTI has launched a 24-month study of an aggressive tumor of the spleen and heart (visceral hemangiosarcoma) using Rametrix Urine Molecular Fingerprinting.